Sepsis Diagnostics Market

7500+ companies worldwide approach us every year for their revenue growth inititatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Sepsis Diagnostics Market

Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 4575 Oct, 2019, by marketsandmarkets.com

[193 Pages Report] The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1% during the forecast period. Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive the demand for sepsis diagnosis during the study period.

Sepsis Diagnostics Market

By technology, the biomarkers segment is expected to grow at the highest rate in the bacterial sepsis diagnosis market during the forecast period

Based on technology, the market is segmented into microbiology, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers. The biomarkers segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the advantages offered by biomarkers such as identification of gram-positive and gram negative infection and helps in differentiating between viral and fungal infections. Also, they help in early identification of sepsis.

By product, the blood culture media segment was the largest contributor to the molecular sepsis diagnostics market market in 2018

The global sepsis diagnostics market is segmented into blood culture media, assays & reagents, instruments, and software. The blood culture media segment commanded the largest share of the global sepsis diagnostics market in 2018. The large share of this segment can be attributed to the increasing use of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis

The automated molecular sepsis diagnostics market segment to register higher CAGR during the forecast period

On the basis of methods, the sepsis diagnostics market is categorized into two segments, namely, conventional diagnostics and automated diagnostics. The automated diagnostics segment is expected to grow at the highest CAGR from 2018 to 2023. Accurate detection of positive blood cultures, quick turnaround time, and reduced risk of contamination is contributing to the growth of this segment

Asia Pacific is expected to grow at the highest CAGR in the molecular sepsis diagnostics market during the forecast period

Geographically, the bacterial sepsis diagnosis market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW). The Asia Pacific is one of the major high growth revenue-generating regions in the sepsis diagnostics market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing number of surgical procedures, improving healthcare infrastructure, and rising number of clinical studies in these emerging countries focusing on the diagnosis of various blood-borne infections including sepsis.

Sepsis Diagnostics Market

Market Dynamics

The sepsis diagnostics market is primarily driven by the rising prevalence of sepsis across the globe. Factors such as the rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and the commercialization and availability of a wide variety of approved sepsis diagnostic devices are also supporting the growth of this market. However, lack of established reimbursement policies for sepsis and the high cost of automated diagnostic devices are the major factors restraining the growth of this market across the globe.

Driver:High incidence of sepsis in adult population

The prevalence of sepsis has increased significantly over the last decade, and the condition is responsible for more number of deaths than other disease conditions, such as bowel and breast cancer combined. The major factors responsible for the significant growth in the prevalence of sepsis include the rising geriatric population, development of drug-resistance among individuals, and rise in virulent varieties of infections. The clinical diagnosis of sepsis infections in geriatric patients is a challenging task. In addition, aging increases the risk of a sudden deterioration in a patient’s condition from sepsis to severe sepsis and septic shock. Thus, sepsis diagnostic instruments play a key role in the accurate and timely diagnosis of the condition in geriatric patients.

Restraint:High cost of automated diagnostic devices

Every year, a large number of people contract sepsis worldwide, and the mortality rate due to sepsis is very high in comparison with other disease conditions. Early and accurate diagnosis of sepsis is very crucial in patients, as the condition can be managed effectively through proper medication and care. These devices are easy to use, fast, and have advanced features, owing to which they cost more as compared to conventional blood culture tests. For instance, the cost of molecular diagnostic tests is between USD 300 and USD 3,000, which is very high as compared to the cost of blood culture tests that are priced as low as ~USD 28–35. Thus, government hospitals (especially in emerging nations) and academic research laboratories generally cannot afford such systems as they have limited budgets, thereby hindering market growth.

Sepsis Diagnostics Market

Scope of the Report

Report Metric

Details

Market Size Available for Years

2016–2023

Base Year Considered

2017

Forecast Period

2018–2023

Forecast Units

Value (USD)

Segments Covered

Technology, Product, Method, Pathogen, Test Type, End Users, and Region

Geographies Covered

North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW (Latin America and Middle East)

Companies Covered

bioMιrieux (France), T2 Biosystems (US), Luminex (US), Becton, Dickinson, and Company (US), Roche Diagnostics (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Bruker (US), Abbott Laboratories (US), Immunexpress (Australia), Response Biomedical Corp. (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), Mitsubishi Chemical Europe (Germany), and EKF Diagnostics Holdings (UK). Major 15 players covered.

This report categorizes the global sepsis diagnostics market into the following segments and subsegments:

Sepsis Diagnostics Market, by Technology

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • Microfluidics
  • Biomarkers

Sepsis Diagnostics Market, by Product

  • Blood Culture Media
  • Assays & Reagents
  • Instruments
  • Software

Sepsis Diagnostics Market, by Pathogen

  • Bacterial Sepsis
    • Gram-positive bacteria
    • Gram-negative bacteria
  • Fungal Sepsis
  • Other Pathogens

Sepsis Diagnostics Market, by Method

  • Conventional Diagnostics
  • Automated Diagnostics

Sepsis Diagnostics Market, by Test Type

  • Laboratory Tests
  • Point-of-care Tests

Sepsis Diagnostics Market, by End User

  • Hospitals
  • Pathology & Reference Laboratories

Sepsis Diagnostics Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)
    • Latin America
    • Middle East & Africa

Key Market Players

bioMιrieux (France), Becton, Dickinson, and Company (US), and Danaher (US) dominated the global sepsis diagnostics market in 2016. Other players include T2 Biosystems (US), Luminex (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), Bruker (US), Abbott Laboratories (US), Immunexpress (Australia), Response Biomedical Corp. (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), Mitsubishi Chemical Europe (Germany), and EKF Diagnostics Holdings (UK), among others.

bioMιrieux SA (France) held the leadership position in the global sepsis diagnostics market in 2016. The company has been focusing new product development and product approvals in the field of sepsis diagnostics. Through this, it introduced innovative products in the market, which enabled it to garner high market share. For instance, bioMιrieux has received approval for several of its products, such as VIDAS B•R•A•H•M•S PCT (Procalcitonin) assay, VIDAS 3 system, VIRTUO system, and FilmArray 2.0 system to offer enhanced diagnostic solutions for better patient care. These launches helped the company strengthen its product portfolio and presence in the sepsis diagnostics market.

Becton, Dickinson, and Company (US) held the second position in the global sepsis diagnostics market in 2016. The company has a diversified portfolio, which includes automated blood culture instruments, blood culture medium, blood culture consumables, and laboratory data management software. The company’s leadership position in the market can be attributed to its strong distribution network in both developed as well as developing countries across the globe, which enables it to serve customers in North America, Europe, Asia Pacific, Eastern Europe, the Middle East, and Africa.

Recent Developments:

  • In 2018, Immunexpress partnered with Biocartis (Belgium) for the development and marketing of SeptiCyte test for using it on Biocartis’s sample-to-result Idylla platform. This helped the company to expand its offerings across the globe.
  • In 2017, bioMιrieux SA (France) received FDA approval for its BacT/ALERT VIRTUO fully automated blood culture system. This helped the company to cater to the increasing demand for sepsis diagnostics across the globe.
  • In 2017, Bruker (US) acquired InVivo Biotech Services GmbH (Germany) to expand its microbiology assay menu for its MALDI Biotyper platform.

Key Questions Addressed by the Report:

  • What are the growth opportunities related to the adoption of sepsis diagnosis across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of technologically advanced (automated) diagnostic systems. Will this scenario continue in the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the new trends and advancements in the sepsis diagnostics market? Are there any new advanced products being developed for early diagnosis?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 24)
    1.1 Objectives Of The Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
           1.4.1 Years Considered For The Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 27)
    2.1 Research Data
         Figure 1 Global Sepsis Diagnostics Market: Research Methodology Steps
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                   Figure 2 Breakdown Of Primary Interviews: By Company Type,Designation,And Region
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
           2.1.3 Market Size Estimation Methodology
           2.1.4 Bottom-Up Approach
           2.1.5 Top-Down Approach
           2.1.6 Research Design
           2.1.7 Market Data Validation And Triangulation
                   Figure 3 Data Triangulation Methodology
           2.1.8 Assumptions For The Study

3 Executive Summary (Page No. - 37)
   Figure 4 Global Sepsis Diagnostics Market,By Product,2018
   Figure 5 Global Sepsis Diagnostics Market,By Technology,2023
   Figure 6 Global Sepsis Diagnostics Market,By Method,2018
   Figure 7 Global Sepsis Diagnostics Market,By Test Type,2018 Vs. 2023
   Figure 8 Global Sepsis Diagnostics Market,By Pathogen,2018
   Figure 9 Global Sepsis Diagnostics Market,By End User,2018
   Figure 10 Global Sepsis Diagnostics Market,By Region,2018 (Usd Million)

4 Premium Insights (Page No. - 42)
    4.1 Sepsis Diagnostics: Market Overview
          Figure 11 Rising Prevalence Of Sepsis Is Driving The Growth Of Sepsis Diagnostics Market Across The Globe
    4.2 Sepsis Diagnostics Market,By Technology
          Figure 12 Microbiology Segment Will Continue To Dominate The Market In 2023
    4.3 Geographic Analysis: Sepsis Diagnostics Market,By Product And Region
          Figure 13 Blood Culture Media Segment To Dominate The Global Sepsis Diagnostics Products Market In 2018
    4.4 Sepsis Diagnostics Market,By Pathogen
          Figure 14 Bacterial Sepsis Segment To Dominate The Sepsis Diagnostics Market During The Forecast Period
    4.5 Sepsis Diagnostics Market,By Method
          Figure 15 Conventional Diagnostics Method To Dominate The Sepsis Diagnostics Market During The Forecast Period
    4.6 Geographic Snapshot Of The Sepsis Diagnostics Market
          Figure 16 Asia Pacific To Register The Highest Cagr During The Forecast Period

5 Market Overview (Page No. - 46)
    5.1 Introduction
    5.2 Market Dynamics
         Figure 17 Sepsis Diagnostics Market: Drivers,Restraints,Opportunities,And Challenges
           5.2.1 Drivers
                    5.2.1.1 High Incidence Of Sepsis In The Adult Population
                    5.2.1.1 Increasing Incidence Of Sepsis In Neonates
                    5.2.1.2 Growing Incidence Of Hospital-Acquired Infections
                    5.2.1.3 Increasing Number Of Surgical Procedures
                    5.2.1.4 Increasing Burden Of Pneumonia
                    5.2.1.5 Influx Of Novel Sepsis Diagnostic Products
                    5.2.1.6 Rising Initiatives To Increase The Awareness And Drive The Adoption Of Sepsis Diagnostic Tests
                    5.2.1.7 Funding For Sepsis-Related Research Activities
           5.2.2 Restraints
                    5.2.2.1 Lack Of Established Reimbursement Policies For Sepsis
                    5.2.2.2 High Cost Of Automated Diagnostic Devices
           5.2.3 Opportunities
                    5.2.3.1 Development Of Rapid Diagnostic/Poc Techniques For Early Sepsis Diagnosis
                    5.2.3.2 Evolution Of Novel Biomarkers For Sepsis Diagnosis
           5.2.4 Challenges
                    5.2.4.1 Lack Of Standard Protocols And Awareness For Sepsis Diagnosis And Treatment
                    5.2.4.2 Shortage Of Skilled Healthcare Professionals

6 Sepsis Diagnostics Market,By Technology (Page No. - 57)
    6.1 Introduction
          Figure 18 Biomarkers Segment To Witness The Highest Growth During The Forecast Period
          Table 1 Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
    6.2 Microbiology
         Table 2 Microbiology Market For Sepsis Diagnosis,By Region,2016–2023 (Usd Million)
    6.3 Molecular Diagnostics
           6.3.1 Polymerase Chain Reaction
           6.3.2 Peptide Nucleic Acid-Fluorescent In Situ Hybridization
           6.3.3 Microarrays
           6.3.4 Syndromic Panel-Based Testing
                   Table 3 Molecular Diagnostics Market For Sepsis Diagnosis,By Region,2016–2023 (Usd Million)
    6.4 Immunoassay
         Table 4 Immunoassay Market For Sepsis Diagnosis,By Region,2016–2023 (Usd Million)
    6.5 Flow Cytometry
         Table 5 Flow Cytometry Market For Sepsis Diagnosis,By Region,2016–2023 (Usd Million)
    6.6 Microfluidics
         Table 6 Microfluidics Market For Sepsis Diagnosis,By Region,2016–2023 (Usd Million)
    6.7 Biomarkers
         Table 7 Biomarkers Market For Sepsis Diagnosis,By Region,2016–2023 (Usd Million)

7 Sepsis Diagnostics Market,By Product (Page No. - 66)
    7.1 Introduction
         Figure 19 Blood Culture Media Segment To Witness Highest Growth During The Forecast Period
         Table 8 Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
    7.2 Instruments
         Table 9 Sepsis Diagnostic Instruments Market,By Region,2016–2023 (Usd Million)
    7.3 Blood Culture Media
         Table 10 Sepsis Diagnostic Blood Culture Media Market,By Region,2016–2023 (Usd Million)
    7.4 Assays & Reagents
         Table 11 Sepsis Diagnostic Assays & Reagents Market,By Region,2016–2023 (Usd Million)
    7.5 Software
         Table 12 Sepsis Diagnostic Software Market,By Region,2016–2023 (Usd Million)

8 Sepsis Diagnostics Market,By Method (Page No. - 73)
    8.1 Introduction
         Figure 20 Conventional Diagnostics Segment To Dominate The Sepsis Diagnostics Market In 2023
         Table 13 Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
    8.2 Conventional Diagnostics
         Table 14 Conventional Diagnostics Market,By Region,2016–2023 (Usd Million)
    8.3 Automated Diagnostics
         Table 15 Automated Diagnostics Market,By Region,2016–2023 (Usd Million)

9 Sepsis Diagnostics Market,By Pathogen (Page No. - 78)
    9.1 Introduction
         Figure 21 Bacterial Sepsis Segment To Register The Highest Growth Rate During The Forecast Period
         Table 16 Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
    9.2 Bacterial Sepsis
         Table 17 Bacterial Sepsis Market,By Type,2016–2023 (Usd Million)
         Table 18 Bacterial Sepsis Market,By Region,2016–2023 (Usd Million)
           9.2.1 Gram-Negative Bacterial Sepsis
                   Table 19 Bacterial Causes Of Adult Sepsis
           9.2.2 Gram-Positive Bacterial Sepsis
                   Table 20 Bacterial Causes Of Adult Sepsis
    9.3 Fungal Sepsis
         Table 21 Fungal Sepsis Market,By Region,2016–2023 (Usd Million)
    9.4 Other Pathogens
         Table 22 Other Pathogens Market,By Region,2016–2023 (Usd Million)

10 Sepsis Diagnostics Market,By Test Type (Page No. - 85)
     10.1 Introduction
            Figure 22 Point-Of-Care Tests Segment To Grow At The Highest Cagr
            Table 23 Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
     10.2 Laboratory Tests
            Table 24 Laboratory Pointers Of Sepsis
            Table 25 Laboratory Tests Market,By Region,2016–2023 (Usd Million)
     10.3 Point-Of-Care Tests
            Table 26 Point-Of-Care Tests Market,By Region,2016-2023 (Usd Million)

11 Sepsis Diagnostics Market,By End User (Page No. - 91)
     11.1 Introduction
            Figure 23 Hospitals Segment To Dominate The Sepsis Diagnostics Market In 2023
            Table 27 Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
     11.2 Hospitals
            Table 28 Sepsis Diagnostics Market For Hospitals,By Region,2016–2023 (Usd Million)
     11.3 Pathology & Reference Laboratories
            Table 29 Sepsis Diagnostics Market For Pathology & Reference Laboratories,By Region,2016–2023 (Usd Million)

12 Sepsis Diagnostics Market,By Region (Page No. - 95)
     12.1 Introduction
            Figure 24 Sepsis Incidence,By Country,2017
            Figure 25 Sepsis Diagnostics Market: Growth Forecast,By Region (2018–2023)
            Table 30 Sepsis Diagnostics Market,By Region,2016–2023 (Usd Million)
     12.2 North America
 Figure 26 North America: Sepsis Diagnostics Market Snapshot
 Table 31 North America: Sepsis Diagnostics Market,By Country,2016–2023 (Usd Million)
 Table 32 North America: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
 Table 33 North America: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
 Table 34 North America: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
 Table 35 North America: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
 Table 36 North America: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
 Table 37 North America: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.2.1 Us
          Table 38 Us: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
          Table 39 Us: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
          Table 40 Us: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
          Table 41 Us: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
          Table 42 Us: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
          Table 43 Us: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.2.2 Canada
          Table 44 Canada: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
          Table 45 Canada: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
          Table 46 Canada: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
          Table 47 Canada: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
          Table 48 Canada: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
          Table 49 Canada: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
     12.3 Europe
 Figure 27 Europe: Sepsis Diagnostics Market Snapshot
 Table 50 Europe: Sepsis Diagnostics Market,By Country,2016–2023 (Usd Million)
 Table 51 Europe: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
 Table 52 Europe: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
 Table 53 Europe: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
 Table 54 Europe: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
 Table 55 Europe: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
 Table 56 Europe: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.3.1 Germany
          Table 57 Germany: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
          Table 58 Germany: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
          Table 59 Germany: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
          Table 60 Germany: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
          Table 61 Germany: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
          Table 62 Germany: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.3.2 France
          Table 63 France: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
          Table 64 France: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
          Table 65 France: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
          Table 66 France: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
          Table 67 France: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
          Table 68 France: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.3.3 Uk
          Table 69 Uk: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
          Table 70 Uk: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
          Table 71 Uk: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
          Table 72 Uk: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
          Table 73 Uk: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
          Table 74 Uk: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.3.4 Rest Of Europe (Roe)
                       Table 75 Roe: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
                       Table 76 Roe: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
                       Table 77 Roe: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
                       Table 78 Roe: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
                       Table 79 Roe: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
                       Table 80 Roe: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
     12.4 Asia Pacific
            Figure 28 Apac: Sepsis Diagnostics Market Snapshot
            Table 81 Apac: Sepsis Diagnostics Market,By Country,2016–2023 (Usd Million)
            Table 82 Apac: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
            Table 83 Apac: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
            Table 84 Apac: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
            Table 85 Apac: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
            Table 86 Apac: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
            Table 87 Apac: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.4.1 Japan
                       Table 88 Japan: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
                       Table 89 Japan: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
                       Table 90 Japan: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
                       Table 91 Japan: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
                       Table 92 Japan: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
                       Table 93 Japan: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.4.2 China
                       Table 94 China: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
                       Table 95 China: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
                       Table 96 China: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
                       Table 97 China: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
                       Table 98 China: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
                       Table 99 China: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.4.3 India
                       Table 100 India: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
                       Table 101 India: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
                       Table 102 India: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
                       Table 103 India: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
                       Table 104 India: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
                       Table 105 India: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.4.4 Rest Of Asia Pacific
                       Table 106 Roapac: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
                       Table 107 Roapac: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
                       Table 108 Roapac: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
                       Table 109 Roapac: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
                       Table 110 Roapac: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
                       Table 111 Roapac: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
     12.5 Rest Of The World
            Table 112 Row: Sepsis Diagnostics Market,By Region,2016–2023 (Usd Million)
            Table 113 Row: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
            Table 114 Row: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
            Table 115 Row: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
            Table 116 Row: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
            Table 117 Row: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
            Table 118 Row: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.5.1 Latin America
          Table 119 Latin America: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
          Table 120 Latin America: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
          Table 121 Latin America: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
          Table 122 Latin America: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
          Table 123 Latin America: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
          Table 124 Latin America: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)
             12.5.2 Middle East & Africa
          Table 125 Middle East & Africa: Sepsis Diagnostics Market,By Technology,2016–2023 (Usd Million)
          Table 126 Middle East & Africa: Sepsis Diagnostics Market,By Product,2016–2023 (Usd Million)
          Table 127 Middle East & Africa: Sepsis Diagnostics Market,By Pathogen,2016–2023 (Usd Million)
          Table 128 Middle East & Africa: Sepsis Diagnostics Market,By Method,2016–2023 (Usd Million)
          Table 129 Middle East & Africa: Sepsis Diagnostics Market,By Test Type,2016–2023 (Usd Million)
          Table 130 Middle East & Africa: Sepsis Diagnostics Market,By End User,2016–2023 (Usd Million)

13 Competitive Landscape (Page No. - 149)
     13.1 Overview
             Figure 29 Key Developments By Leading Market Players In The Sepsis Diagnostics Market,2015–2017
     13.2 Market Share Analysis
             Figure 30 Sepsis Diagnostics Market Share,By Key Players,2016
     13.3 Competitive Scenario
             13.3.1 Product Launches And Approvals,2015–2017
             13.3.2 Partnerships And Collaborations,2015–2018
             13.3.3 Mergers And Acquisitions

14 Company Profiles (Page No. - 153)
(Business Overview, Products Offered, Recent Developments, and MnM View)*
     14.1 Biomιrieux
             Figure 31 Biomιrieux: Company Snapshot
     14.2 T2 Biosystems
             Figure 32 T2 Biosystems: Company Snapshot
     14.3 Luminex
             Figure 33 Luminex: Company Snapshot
     14.4 Becton,Dickinson,And Company (Bd)
             Figure 34 Bd: Company Snapshot
     14.5 Roche Diagnostics (A Subsidiary Of F. Hoffmann-La Roche Ltd.)
             Figure 35 Roche Diagnostics: Company Snapshot
     14.6 Danaher
             Figure 36 Danaher: Company Snapshot
     14.7 Thermo Fisher Scientific
             Figure 37 Thermo Fisher Scientific: Company Snapshot
     14.8 Bruker
             Figure 38 Bruker: Company Snapshot
     14.9 Abbott
             Figure 39 Abbott: Company Snapshot
     14.1 Immunexpress
     14.11 Response Biomedical
     14.12 Axis-Shield Diagnostics
     14.13 Cytosorbents
              Figure 40 Cytosorbents: Company Snapshot
     14.14 Mitsubishi Chemical Europe
     14.15 Ekf Diagnostics
              Figure 41 Ekf Diagnostics: Company Snapshot
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

15 Appendix (Page No. - 189)
     15.1 Discussion Guide
     15.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     15.3 Introducing Rt: Real-Time Market Intelligence
     15.4 Available Customizations
     15.5 Related Reports
     15.6 Author Details 


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 4575
Published ON
Oct, 2019
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Sepsis Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home